Safety, tolerability, pharmacokinetics and pharmacodynamics of GSK2239633, a CC-chemokine receptor 4 antagonist, in healthy male subjects: results from an open-label and from a randomised study

Peer Review reports

Original Submission
27 Aug 2012	Submitted	Original manuscript
Resubmission - Version 2
	Submitted	Manuscript version 2
21 Dec 2012	Reviewed	Reviewer Report - Karl Staples
10 Jan 2013	Reviewed	Reviewer Report - Jagadeesh Bayry
13 Feb 2013	Author responded	Author comments - Anthony Cahn
Resubmission - Version 3
13 Feb 2013	Submitted	Manuscript version 3
14 Feb 2013	Reviewed	Reviewer Report - Karl Staples
23 Feb 2013	Reviewed	Reviewer Report - Jagadeesh Bayry
Resubmission - Version 4
	Submitted	Manuscript version 4
Publishing
26 Feb 2013	Editorially accepted
28 Feb 2013	Article published	10.1186/2050-6511-14-14

Back to article page